Mukesh Chaudhari
机构：HCG Cancer Centre
发表论文 7 篇 · 总被引 89 次 · h-index 2
代表论文
- Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer (2025 · New England Journal of Medicine · 被引 55)
- Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for first-line (1L) treatment of patients (pts) with human epidermal growth factor receptor 2–positive (HER2+) advanced/metastatic breast cancer (a/mBC): Interim results from DESTINY-Breast09. (2025 · Journal of Clinical Oncology · 被引 31)
- D-Dimer: A Primer Biomarker in COVID-19 (2023 · Asian Journal of Medicine and Health · 被引 2)
- A RANDOMIZED CLINICAL TRIAL OF RASAPUSHPADI MALAHARA ON VICHARCHIKA W.S.R. TO ECZEMA (2019 · International Journal of Ayurveda and Pharma Research · 被引 1)
- Abstract RF6-06: Patient-reported outcomes (PROs) in DESTINY-Breast11: neoadjuvant treatment (NAT) with trastuzumab deruxtecan (T-DXd) alone or followed by paclitaxel + trastuzumab + pertuzumab (THP) vs dose-dense doxorubicin + cyclophosphamide followed by THP (ddAC-THP) in high-risk, HER2+ early-stage breast cancer (eBC) (2026 · Clinical Cancer Research)
- Prognostic Significance of D-dimer Levels in Predicting Severity and Mortality in COVID-19 Patients: A Comprehensive Analysis (2025)